Split-Hand-Foot Malformation With Sensorineural Hearing Loss
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
Split-Hand-Foot Malformation With Sensorineural Hearing Loss
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Split hand foot deformity 1
|
0.360 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Claw hand
|
0.150 |
Biomarker
|
disease |
HPO |
|
|
|
Split foot
|
0.130 |
Biomarker
|
disease |
HPO |
|
|
|
Sensorineural Hearing Loss (disorder)
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Aniridia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Syndactyly of fingers
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Congenital absence of hand
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Absence of hand
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Absent finger
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Oligodactyly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
RAPP-HODGKIN SYNDROME
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Rapp-Hodgkin Syndrome (RHS) is a genetic disorder resulting from mutations in the TP63 gene encoding p63 transcription factor. p63 is directly associated with a cis-regulatory element on chromosome 7q21 that controls the expression of DLX5 and DLX6 genes which are involved in craniofacial abnormalities and ectrodactyly or split hand/foot malformation (SHFM).
|
22342398 |
2012 |
Split hand foot deformity 1
|
0.360 |
GeneticVariation
|
disease |
BEFREE |
Split-hand/foot malformation 1 (SHFM1) is caused by chromosomal aberrations involving the region 7q21.3, DLX5 mutation, and dysregulation of DLX5/DLX6 expression by long-range position effects.
|
26839112 |
2016 |
Autism Spectrum Disorders
|
0.010 |
Biomarker
|
disease |
BEFREE |
DLX5 expression was biallelic in two ASD patients and two controls, indicating that DLX5 was not imprinted.There was no mutation in DLX5 in ASD.
|
19195802 |
2010 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
DLX5 (distal-less homeobox 5) promotes tumor cell proliferation by transcriptionally regulating MYC.
|
19497851 |
2009 |
Neoplasms
|
0.050 |
AlteredExpression
|
group |
BEFREE |
DLX5 was frequently upregulated in cell lines derived from several tumor types, including ovarian cancer.
|
21045156 |
2010 |
ovarian neoplasm
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
DLX5 was frequently upregulated in cell lines derived from several tumor types, including ovarian cancer.
|
21045156 |
2010 |
Malignant neoplasm of ovary
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
DLX5 was frequently upregulated in cell lines derived from several tumor types, including ovarian cancer.
|
21045156 |
2010 |
Carcinoma, Ovarian Epithelial
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
DLX5 was frequently upregulated in cell lines derived from several tumor types, including ovarian cancer.
|
21045156 |
2010 |
Neoplasms
|
0.050 |
Biomarker
|
group |
BEFREE |
Dlx5 was required for tumor maintenance via its activation of Notch and Akt, as tumor cells were highly sensitive to Notch and Akt inhibitors.
|
28122332 |
2017 |
Neural Tube Defects
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Dlx5/6-inactivation in the mouse results in a phenotype reminiscent of NTDs characterized by open thoracic and lumbar vertebral arches and failure of epaxial muscle formation at the dorsal midline.
|
30889190 |
2019 |
Split foot
|
0.130 |
GeneticVariation
|
disease |
BEFREE |
A 0.7 Mb de novo duplication at 7q21.3 including the genes DLX5 and DLX6 in a patient with split-hand/split-foot malformation.
|
23169702 |
2012 |
Congenital Foot Deformity
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
A 0.7 Mb de novo duplication at 7q21.3 including the genes DLX5 and DLX6 in a patient with split-hand/split-foot malformation.
|
23169702 |
2012 |
Congenital Foot Deformity
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
A deficiency in expression of Dss1, DLX5 and/or DLX6 during development may explain the SHFM phenotypes.
|
8733122 |
1996 |